Jun. 28 at 4:59 PM
$DNA Since
$ARKK and
$ARKG exited one year ago from their shares of Ginkgo Bioworks, it was the right choice. ARKK is up 59% , ARKG up 2% and DNA is down 23%. Good move by ARK. On the other hand, Ginkgo Bioworks is up 43% in the past 90 days and is beating both. As an ARK observer, selling Ginkgo Bioworks one year ago was one of the more unusual moves after they made HUNDREDS of buys over the previous two years. They know Shyam Sankar (
$PLTR CTO ) quite well and he’s the Board Chairman of Ginkgo. Seems too obvious they will add buying pressure soon at a lower price than their exit. Too much to like.
